Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lantheus Holdings is a US-based pharmaceutical company that develops and commercializes innovative diagnostics and therapeutics. The company focuses on medical imaging and radiopharmaceuticals to improve the detection and treatment of cancer and heart disease. Lantheus significantly contributes to patient care worldwide by offering targeted drugs and diagnostic solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lantheus Holdings is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Lantheus Holdings last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 1.55 USD.
Across its last 3 earnings reports, Lantheus Holdings stock moved by ±4.1% on average the following day. The largest reaction was -6.2% on 11/06/2025; 1 of 3 reactions were positive.
Lantheus Holdings has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.